Daiwei (David) Zhang, PhD, is an Assistant Professor (tenure-track) in the Department of Biostatistics at the University of North Carolina at Chapel Hill School of Medicine, with a joint appointment in the Department of Genetics. His research focuses on developing AI frameworks for analyzing high-dimensional biomedical data, particularly in spatial omics, computational pathology, and medical imaging. Education: MS (Biostatistics) and PhD (Biostatistics and Scientific Computing) from the University of Michigan. Postdoctoral Training: University of Pennsylvania. Research interests include applying machine learning to address biomedical challenges such as tumor heterogeneity, immune interactions, and tissue architecture. His work spans computational methods for spatial transcriptomics, proteomics, and histology integration. Recent publications emphasize spatial multi-omics analysis of cancer ecosystems, tertiary lymphoid structures, and metabolic coordination. These studies leverage advanced machine learning algorithms and interdisciplinary approaches to advance precision medicine. No scientific awards are explicitly mentioned, but his work reflects significant contributions to biomedical AI research. Grants and advising details are not provided in the text.
Ann B. Lee is a Professor and Co-Director of the PhD Program in Statistics at Carnegie Mellon University , with a joint appointment in the Department of Statistics & Data Science and the Machine Learning Department. Prior to joining CMU, she held positions as a J.W. Gibbs Assistant Professor at Yale University and a visiting research associate at Brown University. PhD in Physics, Brown University MSc/BSc in Engineering Physics, Chalmers University of Technology, Sweden Her research focuses on statistical methodology for complex data in the physical sciences , emphasizing trustworthy inference, uncertainty quantification, and integration of classical statistics with machine learning. Recent work includes likelihood-free inference, calibrated forecasting, and diagnostics for generative models. The STAMPS research group , which she co-founded in 2018, hosts weekly meetings and public webinars. In Fall 2024, STAMPS will transition into a CMU Research Center. Recent publications span likelihood-free inference , climate modeling , and astronomy . Notable collaborations include applications to hurricane intensity guidance , galaxy redshift estimation , and cosmological parameter biases . She mentors PhD students and has advised multiple award-winning researchers, including ASA Best Student Paper Award winners. Her teaching includes advanced courses on probability, regression, and AI for climate sciences.
Ranjay Krishna is an Assistant Professor at the Paul G. Allen School of Computer Science & Engineering at the University of Washington, where he co-directs the RAIVN lab and leads the computer vision team at the Allen Institute for AI (Ai2). His research intersects computer vision , natural language processing , robotics , and human-computer interaction . PhD in Computer Science from Stanford University (2021) Bachelor's and Master's degrees from Stanford and Cornell His work has received best paper , outstanding paper , and orals at top conferences like CVPR, ACL, CSCW, NeurIPS, UIST, and ECCV. Media outlets including Science , Forbes , and PBS NOVA have covered his research. He has been supported by grants from Google , Apple , NFS , and others. Ranjay advises a diverse group of 15 PhD and postdoctoral researchers , including Jieyu Zhang, Benlin Liu, and Cheng-Yu Hsieh. His teams have developed benchmarks like MemoryBench and The Colosseum , and his PathFinder framework achieved 74% accuracy in skin melanoma diagnosis—surpassing human experts by 9%. Notable contributions include: Perception Tokens for visual reasoning in MLMs SAM2Act for robotic manipulation with memory Synthetic Visual Genome dataset with 5.6M relationships
Tim Q. Duong, Ph.D., is a Professor at Albert Einstein College of Medicine, affiliated with the Departments of Radiology, Biochemistry, Ophthalmology & Visual Sciences, and Neuroscience. His research focuses on medical imaging, MRI, image analysis, machine learning, and predictive modeling for studying diseases like COVID-19 , neurodegeneration (Alzheimer's, multiple sclerosis), brain injuries , and breast cancer . Develops AI-driven MRI techniques for early disease detection Investigates neuroplasticity in glaucoma and diabetic retinopathy Leads grants from NIH and National Eye Institute Research Trends : Recent publications emphasize AI integration in medical imaging, long-term effects of SARS-CoV-2, and advanced MRI applications for ocular and neurological disorders. Grants include multiple R01 awards for diabetic retinopathy and glaucoma studies. Training Opportunities : Actively recruits postdocs, research coordinators, and faculty. Offers research positions for graduate, medical, and high school students, including Regeneron Scholar programs. Labs & Teams : Leads the Duong Lab at Montefiore Medical Center, focusing on translational research for clinical imaging solutions.
Professor Matthias Mann is a world-leading scientist serving as Director of the Proteomics and Signal Transduction department at the Max Planck Institute of Biochemistry in Martinsried, Germany, and Director of the Proteomics department at the Novo Nordisk Foundation Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Denmark. With an h-index exceeding 277 and over 350,000 citations, he is recognized as the highest cited German researcher and one of the most influential scientists globally in proteomics. His educational background includes: Ph.D. in Chemical Engineering from Yale University (1988) Master's Degree in Physics from Georg August University Göttingen (1984) Bachelor's of Arts in Mathematics from Georg August University Göttingen (1982) Professor Mann's research focuses on advancing mass spectrometry-based proteomics to understand biological systems at the protein level. His work spans technological developments in mass spectrometry, bioinformatics and computational analysis, signal transduction and posttranslational modifications, and clinical proteomics applications for disease diagnosis and treatment. The Mann lab has pioneered groundbreaking methods like SILAC for quantitative proteomics and MaxQuant for proteome data analysis. Their vision is to translate proteomics knowledge into clinical practice for predictive, diagnostic, and preventive medicine, with recent work focusing on AI-guided platforms for analyzing proteomes from minimal tissue samples. Analysis of Professor Mann's recent publications reveals a strong trend toward clinical applications of proteomics, particularly in cancer research, metabolic diseases, and neurodegenerative disorders. His work increasingly integrates spatial proteomics, single-cell resolution techniques, and artificial intelligence approaches to uncover disease mechanisms and identify potential biomarkers, with a clear shift from basic technology development toward direct clinical applications and personalized medicine. Professor Mann has received numerous prestigious awards throughout his career: 2025: Elected member of the American National Academy of Sciences 2024: Dr. H.P. Heineken Award for Biochemistry and Biophysics 2023: Otto Warburg Medal 2019: Nominated member of the Bavarian Academy of Sciences 2013: Elected member of Leopoldina German National Academy of Sciences 2012: Körber European Science Award, Louis-Jeantet Foundation Prize for Medicine, Ernst Schering Prize, and Leibniz Prize Professor Mann leads a highly collaborative research team involved in multiple international networks including the Bill & Melinda Gates Foundation, Michael J. Fox Foundation for Parkinson's Research, CLINSPECT-M, and Munich Heart Alliance. His lab has mentored numerous successful researchers, with several former postdocs receiving prestigious ERC Starting Grants. The Mann group has developed innovative clinical proteomics pipelines for analyzing archived tissue specimens and body fluids, aiming to identify protein markers for early detection of diseases such as diabetes and cancer. The Mann lab operates across two major research centers with state-of-the-art mass spectrometry facilities. Their Clinical Knowledge Graph platform integrates multi-omics data with extensive metadata, creating an ecosystem for machine learning applications in proteomics. Current research focuses on developing highly sensitive methods that can profile thousands of proteins from minimal cell samples, enabling the identification of critical disease-related proteins and supporting the development of individualized therapies.
Dr. Dmytro Matsypura is an Associate Professor in the Discipline of Business Analytics at the University of Sydney Business School. He holds a BA (Hons) from Kyiv Polytechnic Institute (KPI), an MS (Hons) from KPI, and a PhD from the University of Massachusetts Amherst. His research focuses on optimization methodologies, network science, and their applications in finance, transportation, ecology, and graph theory. He is a recipient of multiple teaching awards, including the Wayne Lonergan Outstanding Teaching Award (Early Career) in 2010. Education: PhD in Management Science, University of Massachusetts Amherst (2006) MS (Hons) in Information Systems, Kyiv Polytechnic Institute (2000) BA (Hons) in Business Administration, Kyiv Polytechnic Institute (1998) Research Interests: Dr. Matsypura’s work spans operations research and management science, with a focus on mathematical optimization and network science. His methodological contributions include developing efficient optimization algorithms, while his applied research addresses real-world challenges in finance, engineering, and ecology. Notable applications include wildfire fuel management, portfolio margining, and credit card fraud detection via graph-based models. Awards and Recognition: Teaching Excellence Award (2008, 2013, 2018) Wayne Lonergan Outstanding Teaching Award (Early Career) (2010) Grants and Projects: Current projects include Bushfire Analytics: Optimization of Fuel Reduction (2023, ARC Discovery Project). His research frequently integrates interdisciplinary collaborations, such as applying graph theory to biomedical problems and cybersecurity. Labs/Teams: Active in the Sydney Environment Institute, contributing to projects at the intersection of analytics and sustainability. Collaborates with industry on fraud detection and supply chain optimization.
Prof. Waldemar Kolanus leads the Molecular Immunology and Cell Biology department at the University of Bonn's Life & Medical Sciences Institute (LIMES) . His research bridges immunoregulation , stem cell dynamics , and metabolic stress responses in immune cells. Unit 2 member at LIMES Principal investigator in SFB 704 and ImmunoSensation Cluster Leads a multidisciplinary lab with postdocs, PhD students, and technical staff His work focuses on intracellular signaling pathways connecting immune activation to tissue homeostasis, particularly through: Cytohesin proteins in integrin-mediated adhesion and migration TRIM71 in stem cell regulation and congenital hydrocephalus High-salt environments affecting macrophage function Publication trends show expertise in immune cell migration , genetic models , and chemical inhibition , with frequent use of mice and zebrafish for in vivo studies. Key articles explore: TRIM71's dual role in auditory development and germ cell maintenance Cytohesin family's Golgi regulation and insulin signaling Ruxolitinib's off-target migration inhibition of dendritic cells Contact details: Address: LIMES Institute, Carl-Troll-Straße 31, Bonn Email: kolanus.sekretariat@uni-bonn.de Phone: +49 228 73-62788
Long Cai is a Professor at the California Institute of Technology, affiliated with the Biology and Biological Engineering department. He pioneered the field of spatial genomics and co-developed transformative technologies such as seqFISH and MEMOIR. Research Interests: His work focuses on decoding biological systems through spatial genomics, integrating molecular imaging with computational analysis to uncover cellular organization in tissues. Key areas include developmental biology, neuroscience, kidney regeneration, and cancer biology. Publications: Recent studies highlight applications of spatial transcriptomics in kidney disease, brain nuclear architecture, and multi-omics tissue mapping. His research emphasizes creating high-resolution atlases of cellular dynamics. Scientific Awards: NIH Director’s Pioneer Award (2022) Labs & Collaborations: He leads the Cai Lab, which develops cutting-edge imaging tools in collaboration with the Elowitz Lab and other interdisciplinary teams.
Jennifer L. Clarke is a Professor in the Department of Statistics at the University of Nebraska–Lincoln and Director of the Quantitative Life Science Initiative. She holds leadership roles in enabling big data integration across the University of Nebraska system through collaborative research programs. Her affiliations include the Institute of Agriculture and Natural Resources (IANR) and the College of Agriculture and Natural Resources. Dr. Clarke's research focuses on statistical methodology for high-dimensional data, computational biology, bioinformatics, and bacterial genomics. Her work bridges statistical innovation with applications in oncology, microbiome analysis, and agricultural phenomics. Key areas include predictive modeling, machine learning, and genomic/metagenomic data integration. Her recent publications span cancer biomarker discovery, plant phenotyping methodologies, and microbial community analysis, reflecting her interdisciplinary approach. Articles emphasize translational applications like therapeutic target identification and precision agriculture. Dr. Clarke leads initiatives fostering collaboration between statisticians and domain scientists, including the Quantitative Life Science Initiative and contributions to the Agricultural Genome-to-Phenome Initiative (AG2PI). Her work advances data-driven solutions for healthcare and food security challenges. Notable projects include developing statistical tools for microbiome studies, analyzing root architecture via 3D imaging, and investigating cranberry-derived compounds' cancer-inhibitory mechanisms. Her methodological contributions include hybrid clustering techniques and predictive model validation frameworks.
Dane Morgan is a Professor in the Department of Materials Science & Engineering at the University of Wisconsin-Madison, College of Engineering. His research focuses on computational materials science for materials design, including ab initio electronic structure modeling, multiscale methods, and machine learning applications in materials discovery. His work spans nuclear materials, battery and fuel cell electrodes, and electronic materials. Education : PhD, 1998, University of California, Berkeley MS, 1994, University of California, Berkeley BA, 1992, Swarthmore College Research Interests : Computational materials science, ab initio methods for electronic structure and thermokinetics, machine learning for materials discovery, electrochemical systems modeling, and applications in nuclear materials, batteries, and electronic materials. His work integrates advanced computational techniques with experimental validation. Scientific Awards : 2024 APL Materials, Editors Pick 2023 Microscopy and Microanalysis Best Paper Award (Instrumentation and Software category) 2023 IEEE Transactions on Plasma Science Best Paper Award 2023 Kellet Mid-Career Award 2015 TMS Materials Genome Initiative Ambassador 2006 3M Technical Nontenured Faculty Grant
Professor Guy Williams is a leading academic at the University of Cambridge with a focus on imaging science and clinical neurosciences, affiliated with Downing College and the Wolfson Brain Imaging Centre . Holding a PhD in Physics from his initial Natural Sciences degree, he specializes in nuclear magnetic resonance (NMR) and MRI techniques for brain imaging. Education: BA, PhD in Physics His research centers on non-invasive imaging of brain structure and function, particularly in traumatic brain injury (TBI) and dementia. His work involves developing novel MRI pulse sequences and advanced data analysis algorithms, including AI-based diagnostic tools. He leads studies on white matter integrity post-trauma, longitudinal dementia assessment, and applications of MRI in disorders of consciousness and addiction. Recent publications highlight collaborations in traumatic brain injury outcomes, AI-guided dementia prediction, and neuroimaging of post-COVID cognitive deficits. His team's work on ultra-high field laminar fMRI and distortion correction methods has advanced clinical neuroscience applications. Key techniques include diffusion tensor imaging (DTI), 7 Tesla MRI, and positron emission tomography (PET/MR). His research spans from basic NMR physics to clinical translation, with a strong emphasis on multi-site studies and real-world diagnostic implementation.
Dr. Hongtu Zhu is the Kenan Distinguished Professor of Biostatistics, Statistics, Radiology, Computer Science, and Genetics at the University of North Carolina at Chapel Hill (UNC). He holds affiliations with the Gillings School of Global Public Health and leads the Biostatistics and Imaging Genomics Analysis Lab. His expertise spans statistical learning, medical imaging, AI, and big data integration, with a focus on precision medicine and biomedicine. Dr. Zhu earned his PhD in Statistics from The Chinese University of Hong Kong (2000) and has held prior roles including DiDi Fellow/Chief Scientist (2018-2020) and Bao-Shan Jing Endowed Professor at MD Anderson Cancer Center (2016-2018). He has published over 345 peer-reviewed articles in top-tier journals like Nature, Science, and JASA, and actively contributes to editorial roles including Coordinating Editor of JASA. His research interests include neuroimaging analysis, knowledge graphs, and AI applications in healthcare. Notable awards include the COPSS Snedecor Award (2025), IEEE Fellowship (2025), and IMS Medallion (2027). He has mentored over 80 PhD students/postdoctoral fellows and serves on NIH grant review panels and professional organizations like the ASA's Section on Statistics in Imaging. Key Contributions: Imaging genomics, brain connectivity studies, ridesharing market optimization, medical AI frameworks Lab Innovations: Brain Imaging Genetics Knowledge Portal, Biomedical Knowledge Graph Interface Teaching: Advanced biostatistics courses (Generalized Linear Models, Deep Learning in Biomedicine) Recent work explores causal inference in healthcare, X chromosome's role in neurobiology, and AI ethics in medical vision-language models. His interdisciplinary projects bridge statistics, computer science, and clinical practice to address complex biomedical challenges.
Omer Bayraktar is a Group Leader at the Wellcome Sanger Institute , leading research in the Cellular Genomics Programme. His work focuses on decoding human brain cellular diversity using spatial transcriptomics , imaging , and functional screening to study neural complexity in health and disease. Bayraktar's educational background includes a PhD from HHMI under Chris Doe, investigating neural diversity development in Drosophila , followed by postdoctoral work at University of California, San Francisco and University of Cambridge as a Life Sciences Research Foundation Fellow. He developed a spatial transcriptomic pipeline during his postdoc to analyze astrocyte heterogeneity in the cerebral cortex. His research explores neural cell type mapping , glial-neuronal interactions , and cellular pathways in neurodevelopmental disorders . Recent publications emphasize 3D tissue mapping , multi-omic integration , and computational tools like Cell2fate and WebAtlas. His work bridges neurogenetics and computational biology to advance understanding of human tissue ecosystems. Bayraktar's lab collaborates with the Human Cell Atlas initiative and develops technologies such as automated histology pipelines and highly-multiplexed smFISH for molecular cell typing. His team also investigates glia-based therapies and astrocyte functional heterogeneity in neurodevelopmental contexts. Key scientific contributions include: Discovering astrocyte layer patterns independent of neuronal laminae Developing cell2location for spatial cell mapping Characterizing Drosophila neural stem cell models with human relevance Notable awards include the Life Sciences Research Foundation Fellowship during his postdoctoral training. His current group includes a PhD student , Senior Data Scientists , and Bioinformaticians .
Ruth Etzioni is an Affiliate Professor in the Biostatistics Program and Public Health Sciences Division at the Fred Hutchinson Cancer Center. She leads the Etzioni Lab, focusing on cancer screening, early detection, and overdiagnosis analysis. Her work integrates statistical modeling, epidemiology, and clinical research to address critical questions in prostate and breast cancer control. Dr. Etzioni holds the Rosalie & Harold Rea Brown Endowed Chair and has received a $7.4M NIH Outstanding Investigator Award. Education: PhD in Statistics (Carnegie Mellon University, 1990), MS in Statistics (Carnegie Mellon, 1987), BS in Mathematics (University of Cape Town, South Africa). Research interests emphasize biomarkers, clinical trials, and epidemiological methods. She leads the Biostatistics Core for the Pacific Northwest Prostate Cancer SPORE and participates in the Cancer Intervention and Surveillance Modeling Network (CISNET). Her lab develops models to evaluate screening policies, quantify overdiagnosis, and inform healthcare disparities reduction strategies. Key achievements include groundbreaking work on prostate cancer screening's harm-benefit tradeoffs and contributions to multi-cancer early detection (MCED) frameworks. Recent studies address racial disparities in prostate cancer outcomes, metastasis trends, and the clinical utility of novel diagnostics like PSMA PET imaging. Awards include the Brown Endowed Chair (2020), NCI OIA Award (2023), and recognition for advancing cancer data science. Her lab collaborates with institutions globally and mentors students in biostatistics and translational data science.
Mike Kirby is a Professor at the Kahlert School of Computing, University of Utah. He also holds adjunct professorships in the Department of Bioengineering and the Department of Mathematics. His current roles include leadership in scientific computing and informatics initiatives, including former directorships of the Utah Informatics Initiative (2019-2023) and the Multi-Scale Multidisciplinary Modeling of Electronic Materials (MSME) Collaborative Research Alliance (2016-2022). He has extensive experience in strategic research initiatives, including serving as Assistant Vice President for Research (2024-2025). Education: Dr. Kirby earned a PhD in Applied Mathematics (2002) and MS in Computer Science (2001) from Brown University, and a BS in Applied Mathematics and Computer Science from Florida State University (1997). Research Interests: Focus on large-scale scientific computing, physics-informed machine learning, computational science and engineering, high-order numerical methods, and visualization. His work bridges applied mathematics and computer science to address real-world engineering challenges. Publications: Over 150 peer-reviewed articles, including high-impact contributions in journals like Journal of Computational Physics and SIAM Journal on Scientific Computing . Recent work emphasizes machine learning for differential equations, topology optimization under uncertainty, and multi-fidelity modeling. Awards: Recognized for leadership in computational science and informatics, including contributions to University of Utah’s Clery Compliance Program. Advising & Grants: Supervised over 50 graduate students and postdocs. Secured funding from NSF, DOE, and industry partnerships, totaling millions in research grants. Active in interdisciplinary collaborations across engineering, materials science, and medicine. Labs/Teams: Scientific Computing and Imaging (SCI) Institute, Utah Informatics Initiative, and the Center for Multiscale Modeling of Electronic Materials (MSME).
